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ABSTRACT 
We report the 2DE-based proteomic characterization of the venom of the medically 
important African puff adder, Bitis arietans, after prefractionation by incubation with a 
solid-phase combinatorial hexapeptide ligand library at three different pH values. This 
approach yielded partially overlapping yet clearly distinct sets of proteins. The B. 
arietans venom proteome, merged from the four sets of proteins comprises at least 43 
distinct proteins from 9 toxin families. In line with a previous reverse-phase HPLC-
based venomic characterization on the same species, SVMPs, serine proteinases, C-type 
lectin-like proteins, and to a minor extent PLA2, disintegrin bitistatin, and cystatin, 
comprise the major toxins in the venom of B. arietans. However, the 2D-CPLL 
approach employed here identified both a significantly higher (about double) number of 
proteins than a previous venomic approach, and many very minor components barely, 
or not at all, detectable in the 2DE separation of whole venom. 30 proteins from the 
CPLL-merged venom proteome match any of the 63 toxin clusters generated by 
sequencing one thousand randomly selected venom gland cDNA library clones of the 
same species. The low (47%) concordance between transcriptome and proteome may be 
interpreted in terms of intraspecific venom variation. Comparison of the reverse-phase 
HPLC separations of the venom proteins of B. arietans from Ghana and Nigeria 
supports this view.  
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INTRODUCTION 
Unravelling the total protein composition of complex proteomes is a major challenge of 
current proteomic technologies. This goal is often complicated by the wide dynamic 
range of proteomes, which in the case of human serum, per instance, comprises at least 
nine orders of magnitude [1]. To minimize this problem and allow access to the ‘‘deep 
proteome’’, a number of multidimensional pre-fractionation and tools for 
immunodepleting the most abundant proteins have been described [2-4]. Further, the 
use of a combinatorial library of hexapeptide ligands (Equalizer beads or 
ProteoMiner™, Bio-Rad)  has been shown to allow access to low-abundance proteins 
undetectable by classical analytical methods [5-8]. The use of large peptide libraries 
under overloading conditions to capture and “amplify” low abundance proteins from the 
whole proteome is based on a seminal paper by Thulasiraman et al. [9] and has been 
applied by PG Righetti´s group for exploring the "hidden proteome" of a number of 
biological samples, including human urine [10] and serum [11], human platelets [12], 
human erythrocytes [13], chicken egg white [14] and yolk [15], plant tissues [16], and 
for detecting rare protein impurities [17,18]. Equalizer beads reduce the dynamic range 
of proteomes by simultaneously diluting high-abundance proteins and concentrating 
low-abundance proteins.  
 Recent contributions of the literature of snake venom have underscored the need 
for multifaceted approaches for maximizing proteome coverage [19-21]. Very recently 
we have applied two solid-phase combinatorial hexapeptide ligand libraries to explore 
the occurrence of low-abundance proteins in the venom of Crotalus atrox [22]. C. atrox 
is the largest western rattlesnake and one of the more aggressive rattlesnake species 
found in North America. It is responsible for the majority of snakebite fatalities in 
northern Mexico and for the second greatest number in the USA after C. adamanteus 
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[23]. This study showed the occurrence in the venom of protein spots barely, or not at 
all, detectable in the whole venom, including a C-type lectin-like protein, several PLA2 
molecules, PIII-SVMP isoforms, glutaminyl cyclase isoforms, and a 2-cys 
peroxiredoxin [22]. Peroxiredoxin and glutaminyl cyclase may participate, respectively, 
in redox processes leading to the structural/functional diversification of toxins, and in 
the N-terminal pyrrolidone carboxylic acid formation required in the maturation of 
bioactive peptides such as bradykinin-potentiating peptides and endogenous inhibitors 
of metalloproteases.  
 We have initiated a snake venomics project whose long-term goal is the in-depth 
analysis of viperid venom proteomes [24-26]. Here, we have explored the venom 
proteome of the African puff adder, Bitis arietans. With an average size is about 1 m in 
length and very stout, this species is probably the most common and widespread snakes 
in Africa [20]. Its common occurrence in most sub-Saharan habitats except true deserts 
and rain forests, potent venom, and willingness to bite make B. arietans responsible for 
more fatalities than any other African snake [23, 27-29]. The venom of B.  arietans is 
one of the most toxic of any viper (LD50 values in mice vary from 0.4–2.0 mg/kg i.v., 
0.9–3.7 mg/kg i.p., to 4.4–7.7 mg/kg s.c. [30]), and typically interferes with the 
hemostatic and coagulation systems. B. arietans causes up to 32.000 deaths per year and 
with many more victims ending up with permanent physical disability, due to local 
necrosis, and with psychological sequelae, both of which greatly jeopardize the quality 
of their lives [31]. Defining the deep proteome of B. arietans venom may provide a 
comprehensible catalogue of secreted proteins, which may contribute to a deeper 
understanding of the biological effects of the venom, and may also serve as a starting 
point for studying structure-function correlations of individual toxins. 
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EXPERIMENTAL SECTION 
Enrichment of Bitis arietans venom proteins by treatment with solid-phase 
combinatorial peptide libraries at different pHs 
The lyophilized venom pooled from adult specimens of Bitis arietans (West Africa) was 
purchased from Latoxan (Valence, France). Samples of two hundred mgs of lyophilized 
venom were dissolved at room temperature in 15 mL of the following buffers: 25 mM 
acetate buffer pH 3.82 containing 50 mM potassium chloride, 25 mM phosphate,  50 
mM potassium chloride, pH 7.15, 25 mM Tris-HCl, 50 mM potassium chloride, pH 
9.97, each containing the complete protease inhibitor cocktail (Roche Diagnostics, 
Basel, CH). After centrifugation at 13.000 xg for 10 min (in an Eppendorf centrifuge) to 
pellet non-soluble materials, the three samples were then incubated with 200 μL of 
ProteoMiner™ beads (a mixture of 100 µL of  EBeads + 100 µL of its carboxylated 
version, SE-Beads) pre-equilibrated with the same buffers and the proteins were 
allowed to adsorb to the beads by gentle shacking for 3 hrs at room temperature. The 
solid-phase combinatorial libraries consist of poly(hydroxymetacrilate) beads, each 
displaying the same hexapeptide. The ligand density is ca. 40-60 mmol/mL bead 
volume, and the complete library may contain a set of 64 millions different 
hexapeptides [5]. After washing to remove excess soluble proteins not bound to the 
beads, the flow-though fractions were pooled, and the captured proteins were separately 
eluted from each bead batch in three steps (400 μL + 400 μL + 200 μL) with 7 M urea, 
2 M thiourea, 2% CHAPS and 20 mM cysteic acid, pH 3.3 [32]. The three eluates of 
each sample were pooled and used as such for two-dimensional electrophoretic analysis. 
Peptide libraries and all materials for electrophoresis, such as gel plaques and reagents, 
were from Bio-Rad Laboratories (Hercules, CA, USA).  
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Two-dimensional electrophoresis 
The pH values of the three eluates were adjusted to neutrality and their protein 
concentration adjusted to 2 mg/mL. Disulphide bond reduction was performed at room 
temperature for 60 min by addition of TCEP [Tris(2-carboxyethyl)phosphine 
hydrochloride] to a final concentration of 5 mM. For alkylating sulphydryl groups De-
Streak [Bis-(2-hydroxyethyl)disulphide, (HOCH2CH2)2S2)] was added to the solution at 
a final concentration of 150 mM (by dilution from the 8.175 M stock solution, Sigma-
Aldrich), followed by addition of Ampholine (from the 40% stock solution to a final 
concentration of 0.5%) and a trace amount of bromophenol blue.18-cm long IPG strips 
(Bio-Rad), pH 3-10 NL, were rehydrated with 150 μL of protein solution for 5 h at 
room temperature. Isoelectric focusing (IEF) was carried out using a linear voltage 
gradient from 100 to 1000 V for 5 h, 1000 V for 4 h, followed by an exponential 
gradient up to 10000 V, until each strip was electrophoresed for 25 kV/h. For the second 
dimension, the IPGs strips were equilibrated at room temperature for 25 min in a 
solution containing 6 M urea, 2% SDS, 20% glycerol, 375 mM Tris-HCl (pH 8.8) under 
gentle shaking. The IPG strips were then laid on an 8-18% acrylamide gradient SDS-
PAGE with 0.5% agarose in the cathode buffer (192 mM glycine, 0.1% SDS and Tris-
HCl to pH 8.3). The electrophoretic run was performed by setting a current of 5 mA/gel 
for 1h, followed by 10 mA/gel for 1h and 15 mA/gel until the dye front reached the 
bottom of the gel. Gels were stained with Coomassie Blue and destained in 7% acetic 
acid till clear background, followed by a rinse in distilled water. The 2-DE gels were 
scanned with a Versa-Doc image system (Bio-Rad) by fixing the acquisition time at 10 
sec; the relative gel images were captured via the PDQuest software (Bio-Rad). After 
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filtering the gel images for removing the background, spots were automatically 
detected, manually edited and then counted. 
 
In-gel enzymatic digestion and mass fingerprinting 
Protein bands of interest were excised from Coomassie Brilliant Blue-stained 
2DE gels and subjected to automated reduction with DTT and alkylation with 
iodoacetamide, and in-gel digestion with sequencing grade porcine pancreas trypsin 
(Promega) using a ProGest digestor (Genomic Solutions) following the manufacturer’s 
instructions. 0.65 μL of the tryptic peptide mixtures (from a total volume of ~ 20 μL) 
were spotted onto a MALDI-TOF sample holder, mixed with an equal volume of a 
saturated solution of α-cyano-4-hydroxycinnamic acid (Sigma) in 70% acetonitrile 
containing 0.1% TFA, air-dried, and analyzed with an Applied Biosystems Voyager-DE 
Pro MALDI-TOF mass spectrometer, operated in delayed extraction and reflector 
modes. A tryptic peptide mixture of Cratylia floribunda seed lectin (SwissProt 
accession code P81517) prepared and previously characterized in our laboratory was 
used as mass calibration standard (mass range, 450-3300 Da). 
 
Collision-induced dissociation tandem mass spectrometry (CID- MS/MS)  
For peptide sequencing, the protein digest mixture was loaded in a nanospray 
capillary column and subjected to electrospray ionization (ESI) mass spectrometric 
analysis using a QTrap 2000 mass spectrometer (Applied Biosystems) [33] equipped 
with a nanospray source (Protana, Denmark). Doubly- or triply-charged ions of selected 
peptides from the MALDI-TOF mass fingerprint spectra were analyzed in Enhanced 
Resolution MS mode and the monoisotopic ions were fragmented using the Enhanced 
Product Ion tool with Q0 trapping. Enhanced Resolution was performed at 250 amu/s 
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across the entire mass range. Settings for MS/MS experiments were as follows: Q1- unit 
resolution; Q1-to-Q2 collision energy - 30-40 eV; Q3 entry barrier - 8 V; LIT (linear ion 
trap) Q3 fill time - 250 ms; and Q3 scan rate - 1000 amu/s. CID spectra were interpreted 
manually or using a licensed version of the MASCOT program 
(http://www.matrixscience.com) against a private database containing 1083 viperid 
protein sequences deposited in the SwissProt/TrEMBL database (UniProtKB/Swiss-Prot 
Release 56.7 of 20-Jan-2009; http://us.expasy.org/sprot/) complemented by previously 
assigned peptide ion sequences from snake venomics projects carried out in our 
laboratory [34-43] and contigs assembled from EST sequencing of a B. arietans venom 
gland cDNA library (see below). MS/MS mass tolerance was set to ± 0.6 Da. 
Carbamidomethyl cysteine and oxidation of methionine were fixed and variable 
modifications, respectively. Amino acid sequence similarity searches were performed 
against the available databanks using the BLAST program [44] implemented in the 
WU-BLAST2 search engine at http://www.bork.embl-heidelberg.de.  
 
cDNA library construction and sequencing 
A venom gland cDNA library was constructed from ten wild-caught specimens of B. 
arietans (Nigeria), maintained in the herpetarium of the Liverpool School of Tropical 
Medicine, using identical protocols described for the construction of the venom gland 
cDNA library from E. ocellatus [45]. Briefly, one thousand randomly selected cDNA 
library clones were sequenced in the forward direction (Cogenics, UK) after which low 
quality, contaminating vector sequences and poly A+ tracts were removed using 
Trace2dbEST within the PartiGene pipeline [46] using the same high stringency 
clustering protocols used previously [45], then assembled into contigs before BLAST 
annotation against Uniprot and TrEMBL databases.  
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RESULTS AND DISCUSION 
The Bitis arietans venom proteome merged by CPLL capture at different pHs 
 Recently we have employed solid-phase combinatorial peptide ligand libraries 
(CPLL) to explore the venom proteome of the western diamondback rattlesnake, 
Crotalus atrox [22]. Treatment of the venom with ProteoMiner™ beads under 
overloading conditions resulted in the capture and amplification of several low 
abundance proteins, complementing data gained using our snake venomics protocol [24-
26] towards a more complete description of the venom proteome. Indications in the 
literature of differences in the protein patterns recovered when the same library was 
eluted at slightly acidic or slightly alkaline pH conditions [47], prompted us to explore 
the venom proteome of B. arietans employing a two-dimensional solid-phase 
combinatorial hexapeptide ligand library approach. Indeed, incubation of crude venom 
samples with the ProteoMiner™ beads in different pH conditions resulted in the 
recovery of partially overlapping yet clearly distinct sets of proteins (Fig.1, Table 1). 
Noteworthy, no overall tendency for preferential capturing of acidic versus alkaline 
proteins when the venom was incubated at pH 3.82 or pH 9.97, respectively, was 
observed. On the other hand, 16 proteins (including all 5' nucleotidase and cystatin 
isoforms, a Kunitz-type inhibitor, and the disintegrin bitistatin) were uniquely identified 
in the pooled flow-through (FT) fraction; 10 unique proteins were identified in the pH 
3.82 fraction. This fraction appeared to to be particularly good at capturing C-type 
lectin-like and snake venom metalloproteinases (SVMPs). 1 C-type lectin-like molecule 
(spot 65 in Fig.1C) was exclusively recovered in the set of proteins adsorbed at pH 7.15; 
and 7 unique proteins were found in the pH 9.97 fraction, including the single PLA2 
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protein (spot 78, Fig.1D) identified in the venom proteome. All other proteins were 
shared between two, or more, fractions (Table 1).   
 Differentially captured proteins included both high and low abundance species. 
Many of the latter proteins were barely, if not at all, detectable in the 2DE separation of 
whole venom when the same amount of total proteins were loaded in the IPG strips 
(compare panels A with B-E of Fig.1). Per instance, this is particularly evident in the 
case of the Two-Kunitz inhibitor identified in the heterogeneous series of spots labelled 
50 and 51 in Fig. 1C, the PI-SVMPs in spots 47 and 69 (Fig.1D), the serine proteinase 
28 (Fig.1B) or the L-amino acid oxidase isoform in spot 9 (Fig.1B).  
 The B. arietans venom proteome, merged from the four sets of proteins  
recovered from the CPLL treatment at different pHs, comprises at least 43 distinct 
proteins (Table 1) from 9 toxin families (Fig.2). However, the finding of multiple spots 
sharing peptide mass fingerprint, indicated the existence extensive diversity of isoforms 
among all the major protein families (Table 1). In addition, the characterization of a 
number of serine proteinase, snake venom metalloproteinases (SVMPs) and L-amino 
acid oxidase (LAO) fragments absent in the starting material indicated that proteolysis 
occurred during handling of the samples. Proteolysis during ProteoMiner™ treatment of 
C. atrox venom has been previously reported [22].  
 SVMPs, serine proteinases, and C-type lectin-like (CTL) proteins, and to a 
minor extent PLA2, disintegrin bitistatin, and cystatin, comprise the major toxins in the 
venom of B. arietans (Fig.1A). This view is in general agreement with the outcome of a 
previous reverse-phase HPLC-based proteomic characterization of the same venom 
[48]. Its toxin composition may account for the severe local and systemic symptoms, 
which bites from B.  arietans can produce in humans including cytotoxic and necrotic 
effects, coagulopathies and hemorrhages evident as ecchymosis, incoagulable blood, 
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and swelling. [27,28]. However, the 2D-CPLL approach employed here identified both, 
i) a significantly higher (about double) number of proteins than the previous venomic 
approach [46], and ii) minor novel components (eg., a 5'-nucleotidase found in spots 
104 and 105, Fig.1E and Table 1).  
 
Correlating the B. arietans venom proteome with the venom gland transcriptome 
 The CPLL-merged venom proteome includes 30 proteins encoded by contigs 
sequenced in a venom gland cDNA library of the same species (Table 2). The pseudo 
expression levels of these toxins is displayed in Figure 2. The venom proteome 
comprises also about 14 other proteins (including 1 serine proteinase, 7 CTLs, 2 
SVMPs, and 4 unknown proteins) for which the MS/MS-derived peptide sequences did 
not match to any of the 63 toxin clusters generated by sequencing one thousand 
randomly selected cDNA library clones. In other words, the venom proteome gathered 
by the 2D-CPLL approach and transcriptome share only 47% of components. This 
figure is significantly lower than the 80% concordance between transcriptome and 
proteome reported by us for Echis ocellatus [42].  
 Understandably, the transcriptome covers more than the proteome, especially in 
cases e.g. the SVMPs, when there are many isoforms. This is to be expected since 
separation of proteins with closely related physiochemical properties can be difficult 
and 1000 EST sequences gives quite a considerable depth of random sequencing 
compared to proteomic sampling. However, qualitative discrepancies in the 
compositional agreement of venom acquired  using proteomic and transcriptomic 
approaches have been reported for other species, i.e. Lachesis muta [39] and Bitis 
gabonica gabonica [49]. Intraspecific venom variation represents a well documented 
phenomenon since more than 70 years [50,51], and is particularly notorious among 
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species, which like B. arietans, have a wide distribution range [52]. Intraspecific 
compositional variation between venoms among specimens inhabiting different 
geographic regions may be due to evolutionary environmental pressure acting on 
isolated populations. The occurrence of mRNAs that are abundant and readily 
identifiable in the transcriptome, yet apparently absent from the venom proteome may 
also be explained by a number of factors. Firstly, these messengers may exhibit 
transient, individual or a temporal expression patterns over the life time of the snake. 
Alternatively, mRNAs whose predicted polypeptides were not found to be secreted in 
venom may represent very low-abundance toxins that play a hitherto unrecognised 
physiological function in the venom gland, or may simply represent a hidden repertoire 
of non-translated orphan molecules which may eventually become functional for the 
adaptation of snakes to changing ecological niches and prey habits. At this respect, it 
should be mentioned that the 4 unidentified CTL clusters are relatively small with a 
mean size of 2.3 ESTs; the majority of the 8 unidentified clusters of serine proteinases 
are small (with the exception of one cluster containing 6 ESTs) with a mean size of 2.1 
ESTs; and the unidentified cluster of PLA2 is also small, with a mean size of only 1.5 
ESTs. SVMPs are relatively poorly covered, with only 7 out of a 22 isoforms detected 
in the proteome compared to the transcriptome (Table 2). The unidentified clusters are 
typically small, however, with a mean size of only 1.6 ESTs. The notable exception is 
SVMP (BAR00015) which in the transcriptome is represented with 90 EST copies (by 
far the most abundant venom component) but was not detected in the proteome. One 
possible explanation is that BAR00015 is unstable in venom and has been broken down, 
or represents a case of intraspecific variability. Comparison of the reverse-phase HPLC 
separations of the venom proteomes of B. arietans from Ghana and Nigeria displayed in 
Fig.3 illustrates this point. On the other hand, the discrepancy between the venom 
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proteome and venom gland transcriptome concerning the absence of venom gland 
transcripts matching proteins found in the venom (Table 1) indicates that EST clusters 
assembled from sequences of 1000 random colonies carrying cDNAs  generated from 
the venom gland a small number of geographical restricted (Nigerian) specimens do not 
provide a complete representation of the proteome of a widely distributed species such 
as B. arietans. The ocurrence of intra-species venom variation might be a matter of 
concern from the perspective of the possible consequences on the clinical 
manifestations of envenoming and patient response to antivenom. 
 
Concluding remarks 
Our findings underscore the usefulness of combinatorial peptide libraries as powerful 
tools for mining below the tip of the iceberg. The realization that incubation at different 
pHs results in the capture of distinct sets of venom proteins offers new analytic 
possibilities. The strength of the 2D-CPLL approach resides in its unique capability to 
capture and amplify the concentration of minor proteins, many of which may pass 
unnoticed in a standard proteomic protocol. The Achilles heel of this technique is its 
intrinsic lack of quantitative character. On the other hand, our reverse-phase HPLC-
based snake venomic protocol was developed to address the need of quantifying the 
relative amounts of venom toxins, and is appropriate for characterizing proteins 
representing more than 0.05% of the total venom proteins [24-26]. Abundant venom 
proteins may perform generic killing and digestive functions that are not prey specific, 
low abundance proteins may be more plastic either in evolutionary or ecological 
timescales. Mutations provide the ground on which natural selection operates to create 
functional innovations. A subset of low abundance proteins may serve to “customize” 
an individual venom to feeding on particular prey or may represent orphan molecules 
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evolving under neutral selection "in search for a function". Hence, whereas abundant 
proteins are the primary targets for antivenom therapy, minor components may 
represent scaffolds for biotechnological developments. Proteomic techniques offer their 
full analytical possibilities in the context of a suitable genomic or transcriptomic 
databases. Hence, CPLL, venomic, and transcriptomic approaches complement each 
other towards a complete visualization of venom proteomes. 
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LEGENDS TO FIGURES 
Fig.1. Exploring the venom proteome of C. atrox using combinatorial peptide 
libraries.  
 Colloidal Coomassie blue-stained 2DE maps of crude C. atrox venom (control 
sample) (A), the venom proteins adsorbed to the ProteoMiner™ beads at pHs, 
3.82 (B), 7.15 (C), and 9.95 (D), and the proteins in the flow-through (non-
adsorbed) fraction (E).  Table 1 lists the sets of proteins identified in the different 
fraction.  
 
Fig.2. Comparison of the expression levels of toxin isoforms identified in the set of 
venom proteins adsorbed to the ProteoMiner™ beads at pHs.  
 Distribution of proteins across the 4 fractions captured at different pHs by the 
CLLP approach against their relative representation in terms of number of ESTs 
in each contig of the B. arietans venom gland transcriptome. Asteriks indicate 
protein species uniquely recovered in the corresponding CLLP fraction. SVMP, 
snake venom metalloproteinase; Dis, disintegrin; CTL, C-type lectin-like; LAO, 
L-amino acid oxidase; N´tidase, 5´-nucleotidase; PLA2, phospholipase A2; 
Kunitz-type, Kunitz-type serine proteinase inhibitor; Cystatin, cysteine proteinase 
inhibitor. 
 
Fig.3. Intraspecific geographical venom variation 
 Comparison of the reverse-phase HPLC separations of the venom proteomes of 
Bitis arietans from West Africa (panel A) and Nigeria (panel B). Distinct proteins 
in each venom are labelled with asterisks and their protein families are specified.   
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Figure 2 
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Figure 3 
 
 
 29 
TABLE 1 
Assignment of the 2DE-separated proteins of Bitis arietans venom fractions, obtained after treatment with the combinatorial peptide libraries and 
eluted at different pHs, to protein families by collision-induced fragmentation by nanoESI-MS/MS of selected doubly and tryply-charged tryptic 
peptide ions gathered from in-gel digested protein bands labelled as in panels A-D of Fig.1. X, Ile or Leu. C, carbamidomethylated cysteine residue. 
Numbers correspond to contig identifiers in the transcriptomic database prefixed by a three letter species identifier (e.g. 00127 corresponds to 
BAR00127).  
 
                          2DE spot number               peptide  ion  MS/MS-derived sequence  Protein  
  pH 3.82        pH 7.15        pH 9.97 FT   m/z z 
 
 
1     97  728.3 2  SLPSSPPNVGVCR   Serine proteinase 00127 
       756.8 2  VIGGDECNINEHR 
       571.3 2  VFDYGDWIK    Serine proteinase 00031  
     98  578.7 2  VFDYADWIK    Serine proteinase 00152 
       734.7 2  VIGGAECNINEHR 
       919.3 2  IAPLSLPSSPPTVGSVCR 
       607.8 2  VFDYTDWIR    Serine proteinase 00034 
  55  68 99,100  756.8 2  VIGGDECNINEHR   Serine proteinase 00034 
       494.7 2  ATYWYER 
       607.8 2  VFDYTDWIR 
       647.6 3  IAPFSLPSRPPTVGSVCR 
       636.3 2  VFGDYTDWXR   Serine proteinase 
    74   530.3 2  LFDYSVCR    Serine proteinase [~ Q6T6S7] 00263 
       729.4 2  SLPSNPPSVGSVCR 
       618.1 3  IAPLSLPSNPPSVGSVCR 
    86   785.4 2  LSLPSNPPSVGSVCR   Serine proteinase (fragment) 00263 
    87   764.4 2  ATVAQDACFQFNR   SVMP  (fragment) 00101 
 30 
    88   616.4 2  (157.1)DYFWXGFK   C-type lectin-like 
2       633.3 2  VFNXVEXYR    PIII-SVMP 
       579.3 2  (239.3)SYYDDVK 
       495.8 2  GSSDGYCR 
3     101  825.8 2  XYEXVNXXNEXYR   PIII-SVMP 
       730.3 2  (216.3)CDXAEYCTGR 
       485.8 2  YYFYCR    PIII-SVMP 00077 
       684.3 2  (158.2)ECPXDHFHR   PIII-SVMP 
     102  807.9 2  STYWYELLPAQSR   Serine proteinase 00091 
       607.9 2  VFDYTDWIR 
       756.8 2  VIGGDECNINEHR 
       737.3 3  GDSGGPLICNGQIHGIVEWSR 
     103  537.9 2  LYDYSVCR    Serine proteinase 00031 
       614.9 2  GEFHGIVAWGR 
       571.6 2  VFDYGDWIK 
     104, 105 860.6 2  ETPVLSNPGPYLEFR   Ecto-5´-nucleotidase 00177 
       791.9 2  NVNFPILSANIRPK 
     106  611.8 2  SAGQLYQASLGK   L-amino acid oxidase 00017 
       647.3 2  EGWYANLGPMR 
       742.9 2  EADYEEFLEIAR 
       672.9 3  LNEFVQETENGWYFIK 
4       868.8 2  NGHPCQNNLGYCFR   PIII-SVMP 00027 
       464.9 2  NLGYCFR 
    67,69   764.3 2  ATVAQDACFQFNR   PI-SVMP 00101 
       566.3 2  LANDYGYCR 
       534.2 2  QCISLFGSR 
       847.8 2  LSCEASYLFSDCSR   PIII-SVMP 00377 
5,6,35,36 40-49  70-73 107  857.9 2  VHQYFNTLNEMYR   PIII-SVMP 00042 (and fragments) 
       644.9 2  YINVIVVADQR 
       753.3 2  SASDTLHSFAEWR 
       466.4 2  HSFAEWR 
       796.9 2  SAAVVMNYQPEIDR   PIII-SVMP 00577  
 31 
       557.3 2  CSWNDYNR    PIII-SVMP 00155 
       788.3 3  DFECPVEWCPYDQHCYR  C-type lectin-like [~ Q6T7B6] 
     108  735.3 2  FCYLPAVEGPCR   Kunitz-type inhibitor 00023 
     110  539.9 2  AESFFYCR    SVMP 00076 
       778.6 3  SECDVAEYCTGQSADCPIDR 
     111  468.9 2  VTYVNWR    C-type lectin-like 00287 
       731.3 3  DFQCPSEWSAYGQHCYR 
     112  602.3 3  DVTDPDVQEAAAFAVEK  Cystatin 00172 
       897.9 3  GYQEIQNCNLPPENQQEEITCK 
       665.3 2  VVEAQSQVVDGVK 
       587.3 2  YYLTMELLK 
       398.6 2  IPGGLSPR 
     113  467.9 2  YFWYTR    C-type lectin-like 00475 
       524.9 2  FDYXAYTR 
     114  510.7 2  NPFICEIK    C-type lectin-like 00298  
    90,95   645.4 2  YINVIVVADQR   SVMP 00042 fragment 
       826.6 2  XYEXVNXXNEXYR   SVMP fragment 
       580.3 2  (256.1)WSNGAQXK   C-type lectin-like 
    96   753.3 2  SASDTLHSFAEWR   SVMP fragment 0042 
       557.3 2  CSWNDYNR    PIII-SVMP 00155 
    91   826.6 2  XYEXVNXXNEXYR   SVMP fragment 
       557.3 2  CSWNDYNR    PIII-SVMP 00155   
  58     597.3 3  AVAAIMAHEMGHNLGIR  SVMP fragment 00577 
7-9,24       746.9 2  ADDKNPLEECFR   L-amino acid oxidase 00017 (+ fragments)  
       742.6 2  EADYEEFLEIAR 
10-15       753.4 2  SASDTLHSFAEWR   SVMP 0042 (fragment) 
       466.4 2  HSFAEWR 
       587.6 3  AVAAIMAHEMGHNLGIR  SVMP 00577 (fragment) 
       557.3 2  CSWNDYNR    PIII-SVMP 00155 
       698.1 2  (253.1)AFXCADAGCYCQTR  C-type lectin-like 
 32 
16  56,57,59-63    496.8 2  YDAWIGLR    C-type lectin-like α-chain [JC5058] 00292 
       727.8 2  DEGCLPDWSSYK   C-type lectin-like 
       509.9 2  YDPWSSHK    C-type lectin-like 
       522.9 2  XSSPATGSGXR   unknown 
  64  77   674.3 2  NWQWSDGSIVR   C-type lectin-like 00086 
17  54  75 118,122  688.9 2  CFGLKQYTGFR   C-type lectin-like  00292 
       496.9 2  YDAWIGLR 
       647.9 3  DCLPDWSLYEGHCYR 
     119  888.8 2  WANEESNCFHEQPK   unknown 
    76   728.9 2  (247.2)TNGNXDPWCK   unknown 
  65     832.9 2  (260.1)XEFAEYXSDYR   C-type lectin-like [~ Q6T7B7] 
       639.4 2  STCPFNWXPR 
       854.6 2  QXFCAEXVSYTGYR 
    78   722.3 2  GWGGNGKPIDATDR   D49-PLA2 00538 
       763.8 3  CCFVHDCCYGNLPDCSPK 
       561.2 3  CGWGGNGKPIDATDR 
       539.3 2  ENEAIVCDK   
  66     796.9 2  SAAVVMNYQPEIDR   SVMP fragment 00577 
18       557.3 2  CSWNDYNR    C-type lectin-like 00155 
       796.4 2  SAAVVMNYQPEIDR   SVMP 00577    
19       504.4 2  (243.1)GHNLGIR   SVMP 
       796.4 2  SAAVVMNYQPEIDR   SVMP 00577 
20       645.6 3  FISTHNPQCIHNQPSR   PII-SVMP [Q4JCR9] 00042 
       548.8 2  (230.1)WNDYNR   C-type lectin-like 
21-30       753.4 2  SAAVVMNYQPEIDR   SVMP fragment 00577 
       504.4 2  (243.1)GHNLGIR 
31       557.3 2  CSWNDYNR    C-type lectin-like 00155 
    82-85   753.6 2  SASDTLHSFAEWR   SVMP fragments 00042  
       557.3 2  CSWNDYNR    C-type lectin-like  00155 
 33 
32    80,81 115,116,123 546.6 2  VYDAWIGLR    C-type lectin-like α-chain [Q7LZK5] 00301 
       620.3 2  FVYDAWIGLR 
       698.3 2  CFGLDVHTEYR 
       918.8 3  TQQCSPQWTDGSSVVYENVDEPTK 
       603.3 2  TWTDLPCGEK 
       517.3 2  VGTWEDAEK 
       603.7 2  TWTDLPCGEK 
       831.9 2  FCVENSGHLASIDSK 
       712.4 2  DPGCLPDWSSYK 
    89,92   728.4 2  DEGCLPDWSSYK   C-type lectin-like β-chain [Q7LZK8] 00062 
       655.1 3  ALSDEPICFVAESFHNK 
    93   840.3 2  (279.1)EXXNYVNVFYK  Unknown 
    94   580.2 2  (199.1)GWSNQEXK   Unknown 
  52,53  79 109, 117 788.3 3  DFECPTEWCPYDQHCYR  C-type lectin-like [~ Q6T7B6] 00473 
       860.3 2  SSPDYVWXGXWNQR 
       876.3 2  WTDGSSVXYQNVVER   C-type lectin-like 
33       568.9 2  HDDIFAYEK    L-amino acid oxidase fragment 00017 
34       454.6 2  EESAFVAR    C-type lectin-like 00113 
37       746.9 2  ADDKNPLEECFR   L-amino acid oxidase 00017 (fragment)  
       742.6 2  EADYEEFLEIAR 
       857.9 2  VHQYFNTLNEMYR   PIII-SVMP 00042 
38  50,51     823.6 2  VFAYGGCQVAANNFK   Two-Kunitz inhibitor 00446 
       527.6 2  GPCDEYTGR 
       696.9 2  FYXDPASNECK   Two-Kunitz inhibitor [~ AAR19275] 
39       557.3 2  CSWNDYNR    C-type lectin-like 00155 
       496.9 2  YDAWIGLR    C-type lectin-like α-chain [Q7LZK5] 000292 
       727.9 2  DEGCLPDWSSYK   C-type lectin-like 00012  
     120  728.4 2  DEGCLPDWSSYK   C-type lectin-like β-chain [Q7LZK8] 00062 
     121  674.6 2  NWQWSDGSIVR   C-type lectin-like 00086 
     122  665.7 2  GDWNDDYCTGK   Disintegrin bitistatin 00042 
 34 
       702.5 3  LTPGSQCNYGECCDQCR 
       501.5 2  SSDCPWNH 
 35
Table 2 
Comparison of number of proteins from the different toxin families identified in the 
transcriptome and the  proteome. Full details of the Bitis arietans venom gland 
transcriptome will be reported elsewhere. GO, gene ontology. Toxin class abbreviations 
as in Fig.2. 
 
 
Toxin class GO description Go term Transcriptome Proteome 
SVMP Zn2+metalloendopepti-
dase activity 
GO:0004222 22 8 
SP Serine-type 
endopeptidase activity 
GO:0004252 13 6 
CTL Activators and 
inhibitors of blood 
coagulation 
GO:0005529 14 10 
Disintegrin Inhibitors of integrin 
receptors 
GO:0007229 2 1 
PLA2 Hydrolysis of the 2-
acyl groups in 3-sn-
phosphoglycerides 
GO:0004623 2 1 
LAO Oxidative deamination 
of hydrophobic and 
aromatic L-amino acids 
GO:0001716 2 1 
5’ nucleotidase Catabolism of 
nucleotides 
GO:0008253 2 1 
Kunitz-type 
protease 
inhibitor 
Serine protease 
inhibitor activity 
N/A 3 1 
Cystatin Cysteine protease 
inhibitor activity 
GO:0004869 3 1 
 
 
 
